Melissa M. Wolf

3.2k total citations · 1 hit paper
13 papers, 720 citations indexed

About

Melissa M. Wolf is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Melissa M. Wolf has authored 13 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Melissa M. Wolf's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Melissa M. Wolf is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune cells in cancer (2 papers). Melissa M. Wolf collaborates with scholars based in United States, Spain and Australia. Melissa M. Wolf's co-authors include W. Kimryn Rathmell, Kathryn E. Beckermann, Gabriela Andrejeva, Jeffrey C. Rathmell, Kyung‐min Lee, Mellissa J. Nixon, Katherine E. Hutchinson, Violeta Sánchez, Taekyu Lee and Jennifer M. Giltnane and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Melissa M. Wolf

13 papers receiving 716 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

2017 479 citations Kyung‐min Lee, Jennifer M. Giltnane et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa M. Wolf United States	7	502	306	228	128	103	13	720
Luis J. Schwarz Peru	10	511 1.0×	317 1.0×	319 1.4×	97 0.8×	69 0.7×	17	808
Jian‐Yong Ding China	17	519 1.0×	206 0.7×	270 1.2×	131 1.0×	127 1.2×	32	764
Mellissa J. Nixon United States	7	495 1.0×	269 0.9×	333 1.5×	90 0.7×	208 2.0×	9	808
Joseph Clara United States	6	356 0.7×	186 0.6×	317 1.4×	76 0.6×	153 1.5×	12	638
Xuhong Fu China	12	488 1.0×	137 0.4×	172 0.8×	87 0.7×	77 0.7×	12	712
Tim C. de Ruijter Netherlands	6	605 1.2×	304 1.0×	218 1.0×	191 1.5×	46 0.4×	7	851
Amandine David France	7	319 0.6×	187 0.6×	166 0.7×	246 1.9×	53 0.5×	9	576
Xinghua Han China	15	349 0.7×	289 0.9×	224 1.0×	168 1.3×	66 0.6×	54	676
Grace R. Anderson United States	11	573 1.1×	210 0.7×	190 0.8×	63 0.5×	54 0.5×	13	763

Countries citing papers authored by Melissa M. Wolf

Since Specialization

Citations

This map shows the geographic impact of Melissa M. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa M. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa M. Wolf more than expected).

Fields of papers citing papers by Melissa M. Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa M. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa M. Wolf. The network helps show where Melissa M. Wolf may publish in the future.

Co-authorship network of co-authors of Melissa M. Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa M. Wolf. A scholar is included among the top collaborators of Melissa M. Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa M. Wolf. Melissa M. Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lau, Heather, Kaushik Patra, Melissa M. Wolf, et al.. (2025). Treatment with UX111 Gene Therapy Rapidly Reduced Heparan Sulfate (HS) Exposure in Cerebrospinal Fluid (CSF) and Improved Long-term Cognitive Function in Children with Mucopolysaccharidosis IIIA (MPS IIIA) (S31.001). Neurology. 104(7_Supplement_1). 1 indexed citations

Bacigalupa, Zachary A., Emily N. Arner, Melissa M. Wolf, et al.. (2024). HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma. Journal of Clinical Investigation. 134(12). 7 indexed citations

Wolf, Melissa M., W. Kimryn Rathmell, & Aguirre A. de Cubas. (2023). Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens. Nature Reviews Nephrology. 19(7). 440–450. 11 indexed citations

Taves, Ann, et al.. (2023). The Inventory of Nonordinary Experiences (INOE): Evidence of validity in the United States and India. PLoS ONE. 18(7). e0287780–e0287780. 6 indexed citations

Madden, Matthew Z., Xiang Ye, Emilie L. Fisher, et al.. (2023). Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells. The Journal of Immunology. 211(4). 563–575. 15 indexed citations

Wolf, Melissa M., W. Kimryn Rathmell, & Kathryn E. Beckermann. (2020). Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 39(17). 3413–3426. 111 indexed citations

Madden, Matthew Z., Bradley I. Reinfeld, Melissa M. Wolf, et al.. (2020). Nutrient partitioning in the tumor microenvironment and FDG-PET imaging. The Journal of Immunology. 204(1_Supplement). 240.4–240.4. 1 indexed citations

Chatterjee, Shilpak, Paramita Chakraborty, Anusara Daenthanasanmak, et al.. (2018). Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clinical Cancer Research. 25(3). 1036–1049. 43 indexed citations

Zhang, Qin, Dennis K. Jeppesen, James N. Higginbotham, et al.. (2018). Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cellular and Molecular Gastroenterology and Hepatology. 5(4). 627–629.e6. 33 indexed citations

10.

Andrejeva, Gabriela, Melissa M. Wolf, Marc O. Johnson, et al.. (2018). Metabolomics analysis reveals differential T cell serine metabolism as a target in autoimmunity.. The Journal of Immunology. 200(Supplement_1). 167.7–167.7. 4 indexed citations

11.

Lee, Kyung‐min, Jennifer M. Giltnane, Justin M. Balko, et al.. (2017). MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation. Cell Metabolism. 26(4). 633–647.e7. 479 indexed citations breakdown →

12.

Wolf, Melissa M., et al.. (2009). A Comparison of Heat Versus Methanol Fixation for Gram Staining Bacteria. 35(2). 36–41. 4 indexed citations

13.

Amado, Rafael G., Melissa M. Wolf, Daniel Freeman, et al.. (2008). Association of KRAS mutational status and efficacy of panitumumab monotherapy for the treatment (tx) of metastatic colorectal cancer (mCRC): results of pooled data from 4 clinical studies.. Annals of Oncology. 19(8). 126–126. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact